BBLG

Business Context and Reporting Period

Company: Bone Biologics Corp (BBLG)
Filing Type: Form 8-K (Current Report)
Date of Report: June 28, 2023
Reporting Period: Event date June 28, 2023; Signed July 5, 2023
Context: The Company reported a decision by the Nasdaq Hearings Panel regarding its compliance with the minimum bid price requirement for continued listing on The Nasdaq Capital Market.

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on regulatory listing status and does not contain financial performance data.

Material Changes

Listing Status Update:

• The Nasdaq Hearings Panel confirmed the Company currently demonstrates compliance with Listing Rule 5550(a)(2) regarding the minimum bid price.
• The Company is subject to a "Panel Monitor" status through June 27, 2024.

Outlook, Risks, and Contingencies

Monitoring Period Risks:

• Strict Compliance Requirement: During the one-year monitoring period (through June 27, 2024), the Company must maintain compliance with all listing requirements.
• Consequences of Non-Compliance: If the Company fails to satisfy a continued listing requirement during this period:
  • No opportunity to present a compliance plan to Nasdaq's Listing Qualifications Department.
  • No additional time granted to regain compliance.
  • No applicable cure or compliance period under Rule 5810(c)(3).
  • Immediate opportunity to request an appeal of the determination.
  • Potential delisting of securities from Nasdaq.

Investor Verification Checklist

• Verify the current trading price of BBLG common stock to ensure it remains above the Nasdaq minimum bid price threshold ($1.00) throughout the monitoring period.
• Monitor future 8-K filings for any notices of non-compliance or appeals filed with Nasdaq.
• Review the Company's capitalization and liquidity position in recent 10-Q or 10-K filings, as this 8-K does not contain financial data.
• Confirm the exact expiration date of the Panel Monitor status (June 27, 2024).